FDA Announces an Expansion of Medtronic Pump Recalls
Medtronic expands its FDA insulin pump recall.
Sara is a credited writer, editor, contributor, and essayist, as well as a novelist and poet with more than two decades of experience in media arts. A seasoned publishing professional, she's worked for newspapers, magazines and book publishers in content digitization, editorial, acquisitions and intellectual property. Sara is a member of the International Association of Writers & Editors, has received numerous awards and has been an invited speaker at a Careers in Publishing & Authorship event at Michigan State University and a Reading and Writing Instructor at Sylvan Learning Center. She is also a mental health therapist, clinical supervisor and entrepreneur, holding an MBA degree with a concentration in Marketing and an MA in Clinical Mental Health Counseling (graduating with a 4.2/4.0 GPA). Additionally, she is a member of Chi Sigma Iota, was on her local chapter's board, and a 2020 recipient of the Donald D. Davis scholarship recognizing social responsibility. Sara is certified in children's book writing, HTML coding and social media marketing. Her nine books can be found on Amazon.
Medtronic expands its FDA insulin pump recall.
The neurotoxin lead acetate has been banned from hair products.
Providers see the act as yet another obstacle to collecting on unpaid medical bills.
Some of the top pharmacy chains are at the center of an opioid trial this month in Cleveland.
London researchers are studying cabbies’ brains to inform Alzheimer’s diagnosis.
Study shows white noise can help with cognitive difficulties.
Fentanyl is being added to street drugs at ever-increasing rates.
Iowa’s licensing board deems surgeon incompetent immediately after a patient’s suit is tossed.
McKinsey has consulted for the FDA and opioid drug companies simultaneously for years without reporting any conflicts of interest.
With heightened uncertainty comes social isolation, as well as an increase in both mental health issues and violence.